Target intelligence / Profile preview

Cleavage and polyadenylation factor subunit PCF11 (PCF11)

Target
PCF11
Molecular classification
Other (Cleavage and polyadenylation factor), RNA-processing protein, Transcription termination factor
01

Overview

Cleavage and polyadenylation factor subunit PCF11 (PCF11) is a conserved nuclear protein that is a critical component of the pre-mRNA cleavage and polyadenylation machinery. PCF11 is a scaffold protein with several conserved domains, including a CTD-interacting domain (CID) that binds directly to the C-terminal domain of RNA polymerase II and mediates transcription termination[1][3][4]. It also binds to other polyadenylation factors, such as Clp1, through a conserved binding interface[2]. PCF11 is essential for proper maturation of eukaryotic messenger RNA by coordinating the cleavage of pre-mRNA and addition of the poly(A) tail at the 3’ end, as well as coupling mRNA processing with transcription termination and export. Loss or mutation of PCF11 disrupts these processes, impairs gene expression regulation, and affects cell viability[3][6]. In cancer, PCF11 is associated with metastatic phenotypes due to its role in regulating 3′ untranslated region processing and gene length, with increased or altered activity linked to more invasive disease states[1]. Notes: - PCF11 is not considered a classic therapeutic target such as a receptor or enzyme but is fundamental for mRNA biogenesis and gene regulation. - No known drugs directly target PCF11, and no established use as a clinical biomarker. - Disruption can lead to widespread effects on mRNA processing and cell health, posing challenges for therapeutic modulation.

Other names
Pre-mRNA cleavage complex 2 protein Pcf11KIAA0824Pre-mRNA cleavage complex II protein Pcf11Cleavage and polyadenylation factor subunit, homologPCF11p homolog
02

Biological functions

mRNA 3’-end processing (cleavage and polyadenylation)Transcription termination by RNA polymerase IIRegulation of gene expression (alternative polyadenylation)Coupling mRNA export with transcription terminationCell differentiation, cell proliferation, cell adhesion, migration, and invasion[1][3][4]
03

Disease associations

Cancer (role in tumor cell invasion and metastasis; differential regulation in neuroblastoma and breast cancer)[1]Other (potential involvement via alteration of gene expression or mRNA processing)
04

Safety considerations

Therapeutic targeting may disrupt essential mRNA maturation and gene expression, leading to cell viability issues[6].

Beyond the preview

Go deeper on Cleavage and polyadenylation factor subunit PCF11 (PCF11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cleavage and polyadenylation factor subunit PCF11 (PCF11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call